Cannabis products in BC are getting cheaper and more potent, and its year-over-year sales have doubled between 2019 and 2020, according to a new report from the Canadian Institute for Substance Use Research (CISUR)
Bibliography: All Publications
Council approves EU Drugs Action Plan 2021–2025
The Council of the EU (Foreign Affairs) approved on 21 June the EU Drugs Action Plan for 2021–2025. The new plan presents the concrete actions needed to achieve the priorities of the EU Drugs Strategy, adopted in December 2020 (EMCDDA)
Rise in violence and sexual exploitation against children and young people ‘linked to County Lines’
New research into the criminal exploitation of children has revealed an increase in self-harm and suicide attempts among children and young people admitted into hospital with clear links to County Lines in the illegal drugs trade (University of Nottingham)
Misuse of Drugs Act
Debated on Thursday 17 June 2021 (UK Parliament)
Drug Cryptomarkets in the 2020s
Policy, Enforcement, Harm, and Resilience (gdpo)
Drug-related hospital statistics
A National Statistics publication for Scotland
The Harms of Incarceration
The evidence base and human rights framework for decarceration and harm reduction in prisons – Prisons Briefing (Harm Reduction International)
Quality Standards for Civil Society Involvement in Drug Policy
In this report, the EU Civil Society Forum on Drugs will provide you with guidelines on how to make the involvement of civil society in drug policy more meaningful
Drug Medication Assisted Treatment (MAT) standards: access, choice, support
Evidence based standards to enable the consistent delivery of safe, accessible, high-quality drug treatment across Scotland – download (Scottish Government)
Trends in, and characteristics associated with, trouble accessing sterile needles and syringes among people who inject drugs in Sydney, New South Wales
This bulletin highlights the percentage of participants amongst a sample of people who regularly inject drugs in Sydney, NSW who reported having trouble accessing sterile needles in the past month, from 2011-2019 (NDARC)
Successful ‘click and deliver’ naloxone service delivers lifesaving kits in the post to reduce drug-related deaths
Scottish Families Affected by Alcohol and Drugs (Scottish Families) has issued 348 naloxone kits in its first year of running its online ‘click and deliver’ service. People order online and receive their lifesaving kit in the post a few days later
Public Health England: ‘Preventable bacterial infections remain a problem’
Bacterial infections may be less likely to make the headlines than fatal overdoses and blood-borne viruses, but they are a source of considerable suffering among people who inject drugs (SSA)
New treatment standards for drug users
New standards for treatment for drug users will ensure everyone has access to the support which works best for them (Scottish Government)
50 years of the Misuse of Drugs Act and the ACMD
Despite several amendments over the past five decades, the framework of the Act remains central to drug law today (Society for the Study of Addiction)
Family Drug and Alcohol Courts
This briefing outlines what is different about Family Drug and Alcohol Courts, which uses a problem solving approach to help parents become free from substance misuse, so they can be safely reunited with their children (Centre for Justice Innovation)
Trends in cryptomarkets drug listings January 2020 – January 2021
This bulletin series reports on trends in the availability and type of substances sold on the internet via cryptomarkets over the last 13 months (NDRC)
Latest wastewater data reveal drug-taking habits in a record 82 European cities
The 2020 findings from the largest European project in the science of wastewater analysis are revealed today in Wastewater analysis and drugs — a European multi-city study (EMCDDA)
Failure To Fund
The continued crisis for harm reduction funding in low- and middle-income countries download (HRI)
Crime in England and Wales: year ending December 2020
Rises in drug offences during 2020 compared with 2019 average (ONS)
Drug-related deaths and mortality in Europe: update from the EMCDDA expert network
This report provides an update on drug-related deaths in Europe based primarily on presentations and discussions held at the 2019 meeting of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) expert network on drug-related deaths
Exploring drug supply, associated violence and exploitation of vulnerable groups in Denmark
This report provides an analysis of current drug supply models and the related violence and exploitation of vulnerable groups in Denmark (EMCDDA)
Parents with alcohol and drug problems: using case studies to estimate the cost-benefit of interventions
This guidance supports local areas, organisations and providers that have collected, or intend to collect, case studies to estimate how much social and economic cost they can avoid by supporting families experiencing alcohol and drug problems (Public Health England)
Parents with alcohol and drug problems: guidance for adult treatment and children and family services
The guidance outlines the main issues for families affected by parental alcohol and drug problems and shows how services can work together to support them (Public Health England)
Who’s more likely to be able to get naloxone (Narcan) at their pharmacy?
A look at the socioeconomic factors associated with naloxone availability (Recovery Research Institute)
Standard Operating Procedure for using evidence in ACMD reports
A document developed by the Advisory Council on the Misuse of Drugs (ACMD) to outline the governing process for preparing evidence-based advice
Methamphetamine developments in South Asia
The situation in Iran and the implications for the EU and its neighbours — EU4MD special report (EMCDDA)
Impact of COVID-19 on drug markets, use, harms and drug services in the community and prisons
The results from this study provide a first glimpse into new developments emerging both during and in response to the pandemic, and which could have important implications for the future (EMCDDA)
HHS Releases New Buprenorphine Practice Guidelines, Expanding Access to Treatment for Opioid Use Disorder
The Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder exempt eligible physicians, physician assistants, nurse practitioners, clinical nurse specialists, certified registered nurse anesthetists and certified nurse midwives from federal certification requirements related to training, counseling and other ancillary services that are part of the process for obtaining a waiver to treat up to 30 patients with buprenorphine (SAMHSA)
Patterns of intensive alcohol and other drug treatment service use in Australia, 1 July 2014 to 30 June 2019
This report describes 3 distinct client cohorts based on their patterns of treatment service use between 1 July 2014 and 30 June 2019. Clients who received intensive treatment were more likely than other cohorts to report receiving treatment for multiple principal drugs of concern and for more main treatment types across episodes (AIHW)
Trends in Drug-Induced Deaths in Australia, 1997-2019
Preliminary estimates indicate that there were 1,865 drug-induced deaths among Australians in 2019. This is equivalent to over five drug-induced deaths per day. This is the fifth year in a row where the number of deaths is higher than the earlier peak in the late 1990s (NDARC)
Narcotic Drugs – Estimated World Requirements for 2021
The Report of the International Narcotics Control Board for 2020
Drug Decriminalisation: Progress or Political Red Herring?
Based on the findings from this study INPUD has drawn the following primary recommendations from this report
Taking stock of half a decade of drug policy – An evaluation of UNGASS implementation
This report aims to take stock of progress made on the implementation of the operational recommendations included in the UNGASS Outcome Document (idpc)
Examination of the links between parental conflict and substance misuse and the impacts on children’s outcomes
This report is a literature review examining the links between parental conflict and substance misuse and the impacts on children’s outcomes (UK Government)
Methamphetamine developments in South Asia: the situation in Iran and the implications for the EU and its neighbours — EU4MD special report
The report is the result of research conducted under the EU4Monitoring Drugs (EU4MD) project, funded by the European Commission (EMCDDA)
National Opioid Pharmacotherapy Statistics Annual Data collection
On a snapshot day in 2020, over 53,300 clients received pharmacotherapy treatment for their opioid dependence at 3,084 dosing points across Australia. There were 3,422 authorised prescribers of opioid pharmacotherapy drugs (AIHW)
‘High rollers’ A study of criminal profits along Australia’s heroin and methamphetamine supply chains
This report helps develop an understanding of the quantum of profits being made and where in the value chain they occur. Australians spent approximately A$5.8 billion on methamphetamine and A$470 million on heroin in FY 2019 (ASPI)
What is drug policy evaluation and why is it important?
Timeline of EU drug strategies and plans and their evaluation (EMCDDA)
Edging forward: How the UN’s language on drugs has advanced since 1990 (Version 2
this paper explores a selection of key themes by analysing the consensus based language agreed by UN member states (IDPC)
Death Penalty For Drug Offences: Global Overview 2020
This report, our tenth on the subject, continues our work of providing regular updates on legislative, policy and practical developments related to the use of capital punishment for drug offences, a practice which is a clear violation of international law (Harm Reduction International)
- « Previous Page
- 1
- …
- 6
- 7
- 8
- 9
- 10
- …
- 49
- Next Page »
